Expert Review of Vaccines
Volume 21, 2022 - Issue 4
Open access
7,603
Views
20
CrossRef citations to date
0
Altmetric
Review
COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studies
Manuela Di Fuscoa Pfizer Inc., New York, NY, USACorrespondence[email protected]
https://orcid.org/0000-0003-0079-7331View further author information
, https://orcid.org/0000-0003-0079-7331View further author information
Jay Linb Novosys Health, Green Brook, NJ, USAView further author information
, Shailja Vaghelac HealthEcon Consulting Inc., Ancaster, ON, CanadaView further author information
, Melissa Lingohr-Smithb Novosys Health, Green Brook, NJ, USAView further author information
, Jennifer L. Nguyena Pfizer Inc., New York, NY, USAView further author information
, Thomas Scassellati Sforzolinia Pfizer Inc., New York, NY, USAView further author information
, Jennifer Judya Pfizer Inc., New York, NY, USAView further author information
, Alejandro Canea Pfizer Inc., New York, NY, USAView further author information
& Mary M. Morand Pfizer Inc., Collegeville, PA, USAView further author information
show all
Pages 435-451
|
Received 29 Dec 2021, Accepted 25 Jan 2022, Published online: 03 Feb 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.